4M5P image
Deposition Date 2013-08-08
Release Date 2014-06-25
Last Version Date 2024-10-16
Entry Detail
PDB ID:
4M5P
Keywords:
Title:
OYE2.6 Y78W, I113C
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.50 Å
R-Value Free:
0.16
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
P 63 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:NADPH dehydrogenase
Gene (Uniprot):OYE2.6
Mutations:Y78W, I113C
Chain IDs:A
Chain Length:407
Number of Molecules:1
Biological Source:Scheffersomyces stipitis
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CSD A CYS 3-SULFINOALANINE
Primary Citation
Residues Controlling Facial Selectivity in an Alkene Reductase and Semirational Alterations to Create Stereocomplementary Variants.
ACS catalysis 4 2307 2318 (2014)
PMID: 25068071 DOI: 10.1021/cs500429k

Abstact

A systematic saturation mutagenesis campaign was carried out on an alkene reductase from Pichia stipitis (OYE 2.6) to develop variants with reversed stereoselectivities. Wild-type OYE 2.6 reduces three representative Baylis-Hillman adducts to the corresponding S products with almost complete stereoselectivities and good catalytic efficiencies. We created and screened 13 first-generation, site-saturation mutagenesis libraries, targeting residues found near the bound substrate. One variant (Tyr78Trp) showed high R selectivity toward one of the three substrates, but no change (cyclohexenone derivative) and no catalytic activity (acrylate derivative) for the other two. Subsequent rounds of mutagenesis retained the Tyr78Trp mutation and explored other residues that impacted stereoselectivity when altered in a wild-type background. These efforts yielded double and triple mutants that possessed inverted stereoselectivities for two of the three substrates (conversions >99% and at least 91% ee (R)). To understand the reasons underlying the stereochemical changes, we solved crystal structures of two key mutants: Tyr78Trp and Tyr78Trp/Ile113Cys, the latter with substrate partially occupying the active site. By combining these experimental data with modeling studies, we have proposed a rationale that explains the impacts of the most useful mutations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures